AI summary Trust: medium Third-party lab

LabG tested this tirzepatide batch (2025-t60 1st) at 99.6% purity via HPLC, with mass quantification. The tested quantity of 71.5mg showed a significant 16.4% deviation from the 60mg label, and endotoxin status is not available. The test is older (6-12 months). Customers can cross-check on the lab's public verification URL.

Watch out for
  • high quantity deviation (+16.4%)
  • no endotoxin test
  • older (6-12 months)
Test date
2025-10-01
Purity
99.60% 99.60%
Batch / lot
2025-t60 1st
Lab
LabG
Quantity
label 60mg tested 71.5mg
Qty vs label
+19.2%
+16.4% vs vendor claim
Endotoxins
n/a
Test score
6.2
Manufacturer
Tianjin Finder Chemical Tfc
View vendor dossier
Certificate

Test report image

Certificate scan
Certificate scan as published.
Source

Finnrick

✓ Artifact captured

We have the certificate image (SHA-256 hash captured) — you can verify it loads from the upstream lab and matches the artifact below.

Verify on upstream
Method
HPLC + mass quantification + endotoxins
Test type
finnrick_composite
Dose
60mg
Container
No Label / Silver Crimp / Clear Red Cap
Catalogued
2026-04-16
Artifact hash
2bc5b783df78118c…
This COA is part of TitrateLab's community-trust corpus. See more from Tianjin Finder Chemical Tfc or learn how trust scores are computed on the methodology page.